Authors
Ford, NAffiliation
Médecins Sans Frontières, London EC1N 8QX. nathan.ford@london.msf.orgIssue Date
2003-06-14
Metadata
Show full item recordJournal
BMJ/British Medical JournalPublisher
Published by: BMJ Publishing Group LtdPubMed ID
12805159Additional Links
http://www.bmj.com/cgi/content/full/326/7402/1296Language
enDescription
To obtain this article, click on "Additional Links"ISSN
1468-5833ae974a485f413a2113503eed53cd6c53
10.1136/bmj.326.7402.1296
Scopus Count
Collections
Related articles
- Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
- Authors: James JS
- Issue date: 2001 Feb 28
- [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
- Issue date: 2003 Jul 15
- Uganda cuts AIDS drug deal.
- Issue date: 2001 Feb
- An unequal activism for an unequal epidemic?
- Authors: Selemogo M
- Issue date: 2005 May